To evaluate deep learning (DL)-based models for detecting periapical bone rarefaction (PBRs) in panoramic radiographs (PRs), analyzing their feasibility and performance in dental practice. A search was conducted across seven databases and partial grey literature up to November 15, 2024, using Medical Subject Headings and entry terms related to DL, PBRs, and PRs. Studies assessing DL-based models for detecting and classifying PBRs in conventional PRs were included, while those using non-PR imaging or focusing solely on non-PBR lesions were excluded. Two independent reviewers performed screening, data extraction, and quality assessment using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, with conflicts resolved by a third reviewer. Twelve studies met the inclusion criteria, mostly from Asia (58.3%). The risk of bias was moderate in 10 studies (83.3%) and high in 2 (16.7%). DL models showed moderate to high performance in PBR detection (sensitivity: 26-100%; specificity: 51-100%), with U-NET and YOLO being the most used algorithms. Only one study (8.3%) distinguished Periapical Granuloma from Periapical Cysts, revealing a classification gap. Key challenges included limited generalization due to small datasets, anatomical superimpositions in PRs, and variability in reported metrics, compromising models comparison. This review underscores that DL-based has the potential to become a valuable tool in dental image diagnostics, but it cannot yet be considered a definitive practice. Multicenter collaboration is needed to diversify data and democratize those tools. Standardized performance reporting is critical for fair comparability between different models.

Accurate cortical surface parcellation is essential for elucidating brain organizational principles, functional mechanisms, and the neural substrates underlying higher cognitive and emotional processes. However, the cortical surface is a highly folded complex geometry, and large regional variations make the analysis of surface data challenging. Current methods rely on geometric simplification, such as spherical expansion, which takes hours for spherical mapping and registration, a popular but costly process that does not take full advantage of inherent structural information. In this study, we propose an Attention-guided Deep Graph Convolutional network (ADGCN) for end-to-end parcellation on primitive cortical surface manifolds. ADGCN consists of a deep graph convolutional layer with a symmetrical U-shaped structure, which enables it to effectively transmit detailed information of the original brain map and learn the complex graph structure, help the network enhance feature extraction capability. What's more, we introduce the Squeeze and Excitation (SE) module, which enables the network to better capture key features, suppress unimportant features, and significantly improve parcellation performance with a small amount of computation. We evaluated the model on a public dataset of 100 artificially labeled brain surfaces. Compared with other methods, the proposed network achieves Dice coefficient of 88.53% and an accuracy of 90.27%. The network can segment the cortex directly in the original domain, and has the advantages of high efficiency, simple operation and strong interpretability. This approach facilitates the investigation of cortical changes during development, aging, and disease progression, with the potential to enhance the accuracy of neurological disease diagnosis and the objectivity of treatment efficacy evaluation.

Neuroimaging in ALS has contributed considerable academic insights in recent years demonstrating genotype-specific topological changes decades before phenoconversion and characterising longitudinal propagation patterns in specific phenotypes. It has elucidated the radiological underpinnings of specific clinical phenomena such as pseudobulbar affect, apathy, behavioural change, spasticity, and language deficits. Academic concepts such as sexual dimorphism, motor reserve, cognitive reserve, adaptive changes, connectivity-based propagation, pathological stages, and compensatory mechanisms have also been evaluated by imaging. The underpinnings of extra-motor manifestations such as cerebellar, sensory, extrapyramidal and cognitive symptoms have been studied by purpose-designed imaging protocols. Clustering approaches have been implemented to uncover radiologically distinct disease subtypes and machine-learning models have been piloted to accurately classify individual patients into relevant diagnostic, phenotypic, and prognostic categories. Prediction models have been developed for survival in symptomatic patients and phenoconversion in asymptomatic mutation carriers. A range of novel imaging modalities have been implemented and 7 Tesla MRI platforms are increasingly being used in ALS studies. Non-ALS MND conditions, such as PLS, SBMA, and SMA, are now also being increasingly studied by quantitative neuroimaging approaches. A unifying theme of recent imaging papers is the departure from describing focal brain changes to focusing on dynamic structural and functional connectivity alterations. Progressive cortico-cortical, cortico-basal, cortico-cerebellar, cortico-bulbar, and cortico-spinal disconnection has been consistently demonstrated by recent studies and recognised as the primary driver of clinical decline. These studies have led the reconceptualisation of ALS as a "network" or "circuitry disease".

Pancreatic cystic neoplasms (PCNs) are a complex group of lesions with a spectrum of malignancy. Accurate differentiation of PCN types is crucial for patient management, as misdiagnosis can result in unnecessary surgeries or treatment delays, affecting the quality of life. The significance of developing a non-invasive, accurate diagnostic model is underscored by the need to improve patient outcomes and reduce the impact of these conditions. We developed a machine learning model capable of accurately identifying different types of PCNs in a non-invasive manner, by using a dataset comprising 449 MRI and 568 CT scans from adult patients, spanning from 2009 to 2022. The study's results indicate that our multimodal machine learning algorithm, which integrates both clinical and imaging data, significantly outperforms single-source data algorithms. Specifically, it demonstrated state-of-the-art performance in classifying PCN types, achieving an average accuracy of 91.2%, precision of 91.7%, sensitivity of 88.9%, and specificity of 96.5%. Remarkably, for patients with mucinous cystic neoplasms (MCNs), regardless of undergoing MRI or CT imaging, the model achieved a 100% prediction accuracy rate. It indicates that our non-invasive multimodal machine learning model offers strong support for the early screening of MCNs, and represents a significant advancement in PCN diagnosis for improving clinical practice and patient outcomes. We also achieved the best results on an additional pancreatic cancer dataset, which further proves the generality of our model.

Endovascular Aneurysm Repair (EVAR) is a minimally invasive procedure crucial for treating abdominal aortic aneurysms (AAA), where precise pre-operative planning is essential. Current clinical methods rely on manual measurements, which are time-consuming and prone to errors. Although AI solutions are increasingly being developed to automate aspects of these processes, most existing approaches primarily focus on computing volumes and diameters, falling short of delivering a fully automated pre-operative analysis. This work presents BRAVE (Blood Vessels Recognition and Aneurysms Visualization Enhancement), the first comprehensive AI-driven solution for vascular segmentation and AAA analysis using pre-operative CTA scans. BRAVE offers exhaustive segmentation, identifying both the primary abdominal aorta and secondary vessels, often overlooked by existing methods, providing a complete view of the vascular structure. The pipeline performs advanced volumetric analysis of the aneurysm sac, quantifying thrombotic tissue and calcifications, and automatically identifies the proximal and distal sealing zones, critical for successful EVAR procedures. BRAVE enables fully automated processing, reducing manual intervention and improving clinical workflow efficiency. Trained on a multi-center open-access dataset, it demonstrates generalizability across different CTA protocols and patient populations, ensuring robustness in diverse clinical settings. This solution saves time, ensures precision, and standardizes the process, enhancing vascular surgeons' decision-making.

To develop a novel MRI-based deep learning (DL) diagnostic model, utilizing multicenter large-sample data, for the preoperative differentiation of sinonasal inverted papilloma (SIP) from SIP-transformed squamous cell carcinoma (SIP-SCC). This study included 568 patients from four centers with confirmed SIP (n = 421) and SIP-SCC (n = 147). Deep learning models were built using T1WI, T2WI, and CE-T1WI. A combined model was constructed by integrating these features through an attention mechanism. The diagnostic performance of radiologists, both with and without the model's assistance, was compared. Model performance was evaluated through receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA). The combined model demonstrated superior performance in differentiating SIP from SIP-SCC, achieving AUCs of 0.954, 0.897, and 0.859 in the training, internal validation, and external validation cohorts, respectively. It showed optimal accuracy, stability, and clinical benefit, as confirmed by Brier scores and calibration curves. The diagnostic performance of radiologists, especially for less experienced ones, was significantly improved with model assistance. The MRI-based deep learning model enhances the capability to predict malignant transformation of sinonasal inverted papilloma before surgery. By facilitating earlier diagnosis and promoting timely pathological examination or surgical intervention, this approach holds the potential to enhance patient prognosis. Questions Sinonasal inverted papilloma (SIP) is prone to malignant transformation locally, leading to poor prognosis; current diagnostic methods are invasive and inaccurate, necessitating effective preoperative differentiation. Findings The MRI-based deep learning model accurately diagnoses malignant transformations of SIP, enabling junior radiologists to achieve greater clinical benefits with the assistance of the model. Clinical relevance A novel MRI-based deep learning model enhances the capability of preoperative diagnosis of malignant transformation in sinonasal inverted papilloma, providing a non-invasive tool for personalized treatment planning.

Chronic pain is a multifactorial condition presenting significant diagnostic and prognostic challenges. Biomarkers for the classification and the prediction of chronic pain are therefore critically needed. Here, in this multidataset study of over 523,000 participants, we applied machine learning to multidimensional biological data from the UK Biobank to identify biomarkers for 35 medical conditions associated with pain (for example, rheumatoid arthritis and gout) or self-reported chronic pain (for example, back pain and knee pain). Biomarkers derived from blood immunoassays, brain and bone imaging, and genetics were effective in predicting medical conditions associated with chronic pain (area under the curve (AUC) 0.62-0.87) but not self-reported pain (AUC 0.50-0.62). Notably, all biomarkers worked in synergy with psychosocial factors, accurately predicting both medical conditions (AUC 0.69-0.91) and self-reported pain (AUC 0.71-0.92). These findings underscore the necessity of adopting a holistic approach in the development of biomarkers to enhance their clinical utility.

Alveolar echinococcosis (AE) is a parasitic disease caused by Echinococcus multilocularis, where early detection is crucial for effective treatment. This study introduces a novel method for the early diagnosis of liver diseases by differentiating between tumor, AE, and healthy cases using non-contrast CT images, which are widely accessible and eliminate the risks associated with contrast agents. The proposed approach integrates an automatic liver region detection method based on RCNN followed by a CNN-based classification framework. A dataset comprising over 27,000 thorax-abdominal images from 233 patients, including 8206 images with liver tissue, was constructed and used to evaluate the proposed method. The experimental results demonstrate the importance of the two-stage classification approach. In a 2-class classification problem for healthy and non-healthy classes, an accuracy rate of 0.936 (95% CI: 0.925 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>-</mo></math> 0.947) was obtained, and that for 3-class classification problem with AE, tumor, and healthy classes was obtained as 0.863 (95% CI: 0.847 <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>-</mo></math> 0.879). These results highlight the potential use of the proposed framework as a fully automatic approach for liver classification without the use of contrast agents. Furthermore, the proposed framework demonstrates competitive performance compared to other state-of-the-art techniques, suggesting its applicability in clinical practice.

The purpose of this study was to investigate the utility of deep learning image reconstruction at medium and high intensity levels (DLIR-M and DLIR-H, respectively) for better delineation of liver metastases in pre-contrast and post-contrast CT, compared to conventional hybrid iterative reconstruction (IR) methods. Forty-one patients with liver metastases who underwent abdominal CT were studied. The raw data were reconstructed with three different algorithms: hybrid IR (ASiR-V 50%), DLIR-M (TrueFildelity-M), and DLIR-H (TrueFildelity-H). Three experienced radiologists independently rated the lesion conspicuity of liver metastases on a qualitative 5-point scale (score 1 = very poor; score 5 = excellent). The observers also selected each image series for pre- and post-contrast CT per patient that was considered most preferable for liver metastases assessment. For pre-contrast CT, lesion conspicuity scores for DLIR-H and DLIR-M were significantly higher than those for hybrid IR for two of the three observers, while there was no significant difference for one observer. For post-contrast CT, the lesion conspicuity scores for DLIR-H images were significantly higher than those for DLIR-M images for two of the three observers on post-contrast CT (Observer 1: DLIR-H, 4.3 ± 0.8 vs. DLIR-M, 3.9 ± 0.9, p = 0.0006; Observer 3: DLIR-H, 4.6 ± 0.6 vs. DLIR-M, 4.3 ± 0.6, p = 0.0013). For post-contrast CT, all observers most often selected DLIR-H as the best reconstruction method for the diagnosis of liver metastases. However, in the pre-contrast CT, there was variation among the three observers in determining the most preferred image reconstruction method, and DLIR was not necessarily preferred over hybrid IR for the diagnosis of liver metastases.

According to the updated classification system, human epidermal growth factor receptor 2 (HER2) expression statuses are divided into the following three groups: HER2-over-expression, HER2-low-expression, and HER2-zero-expression. HER2-negative expression was reclassified into HER2-low-expression and HER2-zero-expression. This study aimed to identify three different HER2 expression statuses for breast cancer (BC) patients using PET/CT radiomics and clinicopathological characteristics. A total of 315 BC patients who met the inclusion and exclusion criteria from two institutions were retrospectively included. The patients in institution 1 were divided into the training set and the independent validation set according to the ratio of 7:3, and institution 2 was used as the external validation set. According to the results of pathological examination, all BC patients were divided into HER2-over-expression, HER2-low-expression, and HER2-zero-expression. First, PET/CT radiomic features and clinicopathological features based on each patient were extracted and collected. Second, multiple methods were used to perform feature screening and feature selection. Then, four machine learning classifiers, including logistic regression (LR), k-nearest neighbor (KNN), support vector machine (SVM), and random forest (RF), were constructed to identify HER2-over-expression vs. others, HER2-low-expression vs. others, and HER2-zero-expression vs. others. The receiver operator characteristic (ROC) curve was plotted to measure the model's predictive power. According to the feature screening process, 8, 10, and 2 radiomics features and 2 clinicopathological features were finally selected to construct three prediction models (HER2-over-expression vs. others, HER2-low-expression vs. others, and HER2-zero-expression vs. others). For HER2-over-expression vs. others, the RF model outperformed other models with an AUC value of 0.843 (95%CI: 0.774-0.897), 0.785 (95%CI: 0.665-0.877), and 0.788 (95%CI: 0.708-0.868) in the training set, independent validation set, and external validation set. Concerning HER2-low-expression vs. others, the outperformance of the LR model over other models was identified with an AUC value of 0.783 (95%CI: 0.708-0.846), 0.756 (95%CI: 0.634-0.854), and 0.779 (95%CI: 0.698-0.860) in the training set, independent validation set, and external validation set. Whereas, the KNN model was confirmed as the optimal model to distinguish HER2-zero-expression from others, with an AUC value of 0.929 (95%CI: 0.890-0.958), 0.847 (95%CI: 0.764-0.910), and 0.835 (95%CI: 0.762-0.908) in the training set, independent validation set, and external validation set. Combined PET/CT radiomic models integrating with clinicopathological characteristics are non-invasively predictive of different HER2 statuses of BC patients.